Our modular receptors unlock a new era of safer, cost-effective, and potent treatments for cancer and autoimmune disease.
Despite enormous potential, CAR-T therapy remains limited by its high toxicity and poor therapeutic persistence, especially in the context of solid tumors.
More persistent immune response prevents disease relapse
Complex and logic gated signalling: Modular receptors can be customized and optimized for specific applications
Compatible across immune cells: Functionality tested in T cells, NK cells, monocytes, macrophages, dendritic cells
Compatible with iPSC/ stem cells:MARC expressing stem cells/iPSCs can recreate the entire immune system
Scalable and cost-effective